ATE155345T1 - Gegengift immunsera - Google Patents

Gegengift immunsera

Info

Publication number
ATE155345T1
ATE155345T1 AT92909065T AT92909065T ATE155345T1 AT E155345 T1 ATE155345 T1 AT E155345T1 AT 92909065 T AT92909065 T AT 92909065T AT 92909065 T AT92909065 T AT 92909065T AT E155345 T1 ATE155345 T1 AT E155345T1
Authority
AT
Austria
Prior art keywords
antivenox
immune sera
antivenom
species
disclosed
Prior art date
Application number
AT92909065T
Other languages
English (en)
Inventor
Damon Charles Smith
Original Assignee
Therapeutic Antibodies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutic Antibodies Inc filed Critical Therapeutic Antibodies Inc
Application granted granted Critical
Publication of ATE155345T1 publication Critical patent/ATE155345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/804—Drug, bio-affecting and body treating compositions involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nonwoven Fabrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Packages (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT92909065T 1991-05-02 1992-04-24 Gegengift immunsera ATE155345T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919109478A GB9109478D0 (en) 1991-05-02 1991-05-02 Antivenoms

Publications (1)

Publication Number Publication Date
ATE155345T1 true ATE155345T1 (de) 1997-08-15

Family

ID=10694329

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92909065T ATE155345T1 (de) 1991-05-02 1992-04-24 Gegengift immunsera

Country Status (12)

Country Link
US (1) US6833131B1 (de)
EP (1) EP0583281B1 (de)
JP (1) JP3666872B2 (de)
AT (1) ATE155345T1 (de)
AU (1) AU672172B2 (de)
DE (1) DE69220939T2 (de)
DK (1) DK0583281T3 (de)
ES (1) ES2106183T3 (de)
GB (2) GB9109478D0 (de)
GR (1) GR3024907T3 (de)
RU (1) RU2114636C1 (de)
WO (1) WO1992019280A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2222993A1 (en) * 1998-02-04 1999-08-04 The Ontario Cancer Institute A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
US6709655B2 (en) 2001-02-28 2004-03-23 Instituto Bioclon, S.A. De C.V. Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof
RU2228194C2 (ru) * 2002-07-08 2004-05-10 Вискунов Владимир Георгиевич Средство, предотвращающее развитие геморрагического, кровесвертывающего и отчетно-некротического действия яда змеи при отравлении им организма
US20090156417A1 (en) * 2005-09-26 2009-06-18 Jean Gariepy Library From Toxin Mutants, And Methods Of Using Same
CN101385855B (zh) * 2006-05-19 2011-11-16 成都军区疾病预防控制中心昆明军事医学研究所 精制多价抗蛇毒冻干血清的方法
CN101347617B (zh) * 2006-06-02 2011-04-06 成都军区疾病预防控制中心军事医学研究所 精制多价抗蛇毒冻干血清及使用方法
SG181707A1 (en) * 2009-12-18 2012-07-30 Sanofi Sa Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
USD693411S1 (en) * 2012-03-30 2013-11-12 Stelulu Technology Inc. Foot board
CN106008713A (zh) * 2016-08-05 2016-10-12 安徽威尔试剂盒科技有限责任公司 一种尖吻蝮蛇毒高效价抗血清的制备方法及其应用
CN106243224A (zh) * 2016-08-05 2016-12-21 安徽威尔试剂盒科技有限责任公司 一种利用尖吻蝮蛇毒特异蛋白制备抗血清的方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053492A (en) * 1986-08-07 1991-10-01 Board Of Regents, The University Of Texas System Immunopurification using monoclonal antibodies to Mojave toxin
US4806346A (en) * 1986-12-16 1989-02-21 American Home Products Corporation Method for isolation of antigen specific immunoglobulin
DE3920713A1 (de) 1989-06-24 1991-01-10 Bosch Gmbh Robert Insassen-sicherheitseinrichtung fuer fahrzeuge
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms

Also Published As

Publication number Publication date
US6833131B1 (en) 2004-12-21
JP3666872B2 (ja) 2005-06-29
DK0583281T3 (da) 1997-08-25
GB9322377D0 (en) 1994-02-09
DE69220939D1 (de) 1997-08-21
GB2271509A8 (en) 2000-03-27
AU672172B2 (en) 1996-09-26
EP0583281B1 (de) 1997-07-16
GB2271509A (en) 1994-04-20
AU1677492A (en) 1992-12-21
DE69220939T2 (de) 1997-11-20
GB9109478D0 (en) 1991-06-26
WO1992019280A1 (en) 1992-11-12
RU2114636C1 (ru) 1998-07-10
EP0583281A1 (de) 1994-02-23
GR3024907T3 (en) 1998-01-30
JPH06506928A (ja) 1994-08-04
GB2271509B (en) 1995-03-08
ES2106183T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
GR3024025T3 (en) Composition and method of treating hepatitis c.
FI950587A7 (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
DE69434223D1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE69430903D1 (de) Behandlung von periodontitis mit misoprostol
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
EP0206529A3 (de) Behandlung oraler Krankheiten
DE69329558D1 (de) Verfahren zur Behandlung von Multiplesklerose
NO901141D0 (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
ATE155345T1 (de) Gegengift immunsera
FI870484A7 (fi) Tekstiilinkäsittelykoostumus ja -menetelmä.
FR2491334B1 (de)
KR900700406A (ko) 석면처리제 및 처리법
DE3381624D1 (de) Mittel zur behandlung von wunden.
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
NO902620D0 (no) Drivstoff og brenselbehandling.
FI944687L (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
DE3884652D1 (de) Gate-Ausschaltthyristor und Verfahren zu dessen Herstellung.
FI960839L (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
EP0153710A3 (de) Aus Pseudomonas aeruginosa stammende Elastase-Toxoide
DK0471040T3 (da) Anvendelse af cromakalim/BRL 38227 til behandling af hyperreaktivitet i luftveje
ATE287538T1 (de) Verfahren zur immunchemischen quantifizierung von inaktivierten, immunreaktiven antigenen
FI894048L (fi) Menetelmä Pseudomonas aeruginosa-infektioita vastaan vaikuttavien valmisteiden sekä immunoglobuliini-G-pitoisten, Pseudomonas aeruginosa-bakteeria vastaan vaikuttavien valmisteiden tuottamiseksi
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee